Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. - Wikidata - wikimedia - TriplyDB

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

http://www.wikidata.org/entity/Q37470015

about

Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger Nitric oxide and bone Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity Mechanical force enhanced bony formation in defect implanted with calcium sulphate cement Orthodontic force stimulates eNOS and iNOS in rat osteocytes Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat.Blood flow controls bone vascular function and osteogenesis.Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis The autoinhibitory control element and calmodulin conspire to provide physiological modulation of endothelial and neuronal nitric oxide synthase activity.Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.Mechanisms balancing skeletal matrix synthesis and degradation.Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women Osteosarcopenic obesity: the role of bone, muscle, and fat on health Exercise training augments regional bone and marrow blood flow during exercise.Aging and estrogen status: a possible endothelium-dependent vascular coupling mechanism in bone remodeling.Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms.The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]Novel therapies for osteoporosis.Antiosteoporosis Activity of New Oriental Medicine Preparation (Kyungokgo Mixed with Water Extract of Hovenia dulcis) on the Ovariectomized Mice Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption.Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase Estrogen regulates the expression and activity of epithelial sodium channel in mouse osteoblasts Effects of skeletal unloading on the vasomotor properties of the rat femur principal nutrient artery Calcium sensing and cell signaling processes in the local regulation of osteoclastic bone resorption.Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses.iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.Effect of raloxifene treatment on osteocyte apoptosis in postmenopausal women.Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption Organic nitrates for osteoporosis: an update.Increased risk of osteoporosis in patients with erectile dysfunction: A nationwide population-based cohort study.Oxytocin is an anabolic bone hormone Oxidative stress, free radicals and bone remodeling.Organic nitrate maintains bone marrow blood perfusion in ovariectomized female rats: a dynamic, contrast-enhanced magnetic resonance imaging (MRI) study Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss.Nitrates and bone turnover (NABT) - trial to select the best nitrate preparation: study protocol for a randomized controlled trial.Review: The diabetic bone: a cellular and molecular perspective.Nitric oxide donors for the treatment of osteoporosis.The effects of organic nitrates on osteoporosis: a systematic review.

P2860

Q24559960-38931D65-DAA4-44E0-A3BE-F97504C03080 Q28343869-70E15CA3-06AD-48E7-A2D6-825A3C1175F2 Q28345673-2C2BD45A-946C-46C4-84C9-F7AA654C21A6 Q28396715-38789781-0C29-462B-8AFC-F0517B6BE2F4 Q28572099-54DFEB57-C881-4918-92F3-90BC3EF6DECC Q30633470-4DC0CBC4-26ED-4259-ABA0-C54A66687056 Q30831553-94AD6648-3B68-4EE7-8DFC-2041107A74A0 Q33793981-11C9DE1E-7637-4EE2-90D1-1408B0021232 Q33848398-847FBB29-AEC6-49D3-920A-2145A1D006A8 Q34002676-2EA700C2-1C8E-4C8A-A1E9-38A1A952E3F8 Q34129759-263BB1E3-8050-4035-88C1-5B04692C970F Q34138159-2936FB70-6F41-4F2B-AB70-CB07DA012ED6 Q34139780-674C92FD-FDB4-40BC-A524-88EB5AACADA8 Q34156977-9875A4B4-43F5-4004-BCE0-78A34EE50B07 Q34216995-730BDB41-69E8-40C4-804D-270F0C77E2D5 Q34489715-66206F87-8AFA-48A0-B9D8-0F63DDCD5AEE Q34520984-58A2549A-9469-4448-8417-7CE754766AD8 Q34646490-7E1E609A-C36B-4179-9B50-0108A8FEFBF4 Q35094675-292483B8-434F-4492-A525-43528CB0F61F Q35110124-41FC6F99-7316-4E81-96EA-050E45F8E86E Q35174052-B753AF4D-44B3-4881-88CC-A55FD0223D65 Q35183474-57E43B4E-DB4F-4BDF-B67C-8054EE7E5BD9 Q35215815-11571CB4-3BE5-48F0-8B49-896FBFF22F91 Q35437616-891048AB-4A83-480E-B489-8E50931FB482 Q35684029-AC8846E6-882F-4BB6-9BBD-FD56F046D21F Q35764252-42D7654D-5277-489E-B2E4-A4E0FD46F00D Q35991875-37808B63-33E8-43AB-88C6-49E66BE3D04E Q36060627-F443D8E4-1857-4187-9402-838918C5B3D8 Q36087523-3CC0A70D-7EA0-4466-9C2F-4E6D6D28F7DA Q36290634-A8997BE5-F445-4333-A022-EB8EE7627CFD Q37043897-0DBFC05B-1C72-41A6-8802-FEEBD5E9E02D Q37078002-383C1511-E61B-4861-A312-F21091E1FD11 Q37182727-634B271B-445D-45DC-9DB2-3CD24B4C8C3C Q37291314-834E0519-0DA6-4199-A7ED-5C584BA6C545 Q37327868-675E06A5-A9D3-4998-AA78-2C872D26ED44 Q37341848-D8A8B712-5DC0-4108-80A9-55A61D8343AD Q37358034-203AD17D-0E9D-4EBB-BFDF-44B206C15BBD Q37858842-2B3464B8-4D21-48CC-BF71-B27ABA7BD52D Q37972582-49C7BB38-14DC-417B-B693-3329AD589D59 Q38073120-1C30FA2D-A0AD-4134-A1C2-160CC0A92884

P2860

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

http://www.wikidata.org/entity/Q37470015

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 1991

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

@en

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

@nl

type

label

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

@en

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

@nl

prefLabel

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

@en

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

@nl

P1433

Q37470015-829BC58A-AD92-447C-9B0E-4A09C90E8794

P1476

Q37470015-7B8DE12A-5828-4FA7-A46D-975AB776B2D2

P2093

Q37470015-06EBDEC4-A9A1-4D15-8593-9606CBD96A42

Q37470015-091B3940-605C-45C7-8542-8B4F0DB413EF

Q37470015-0D20BAB9-E2B2-4931-8E25-7B0BCD9AEA27

Q37470015-2439D22F-29E2-45EF-95B4-D33789C8EB93

Q37470015-4B0A44FF-A0C4-47A1-B552-362C0A7493F2

Q37470015-68FCA5F3-1B53-4EFE-8397-60F23786A612

Q37470015-A91A53C1-4BA0-4094-BF62-23EA9EC9E63A

Q37470015-D629617E-DDFC-4179-BA7B-A3215D1D5F6B

P2860

Q37470015-076212F4-6A50-4C49-8280-F3A03BD2A11D

Q37470015-0B41A78D-8A27-4C88-8C15-9BD8E1F0CB61

Q37470015-1B5D19D2-8EC1-4D90-8AA0-5ABAECCEDD6E

Q37470015-220A5C6F-F707-446D-B468-77D1B71BF2A4

Q37470015-27B3E505-93FD-4628-9CD0-C32430275F5C

Q37470015-2B775DE1-A3A9-49D1-95DD-F7A579B3CB16

Q37470015-32637787-48F9-483D-8135-762E37F2ED73

Q37470015-478301CC-3ED8-483B-BAAD-7B3FD983DC37

Q37470015-4A37FA1A-937E-4DAD-AEEB-54B6C4832434

Q37470015-A0ABFF53-B146-4DD0-9E4E-A5545087390B

P304

Q37470015-6DC4E719-2A0C-448D-807F-D7C9167D2CE7

P31

Q37470015-7A563006-DB1F-43CC-9F18-5DEEBB9DD80B

P356

Q37470015-C8BFEC2D-5417-4F3A-9085-7ED8FC39B0D6

P407

Q37470015-4B0AE4B4-6A48-443C-9584-95609AC705F2

P433

Q37470015-3FDF3C77-8E49-4322-AC49-2B9C6215F61F

P478

Q37470015-D91E9E29-AFEA-4D8D-A963-B1992760EB4F

P577

Q37470015-CA68B2BC-22A8-4F8B-86B3-029C7B6A161A

P5875

Q37470015-FA74DB50-0ED8-4BCD-AD8A-CDED6498EC4A

P698

Q37470015-85A91560-337B-4391-8334-4976DC688A4F

P932

Q37470015-EE343EFB-27DB-4D67-BEE6-8F8EE9E5DD75

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

@en

P2093

Alam AS

http://www.w3.org/2001/XMLSchema#string

Datta HK

http://www.w3.org/2001/XMLSchema#string

Hecker M

http://www.w3.org/2001/XMLSchema#string

Lidbury PS

http://www.w3.org/2001/XMLSchema#string

MacIntyre I

http://www.w3.org/2001/XMLSchema#string

Moonga BS

http://www.w3.org/2001/XMLSchema#string

Vane JR

http://www.w3.org/2001/XMLSchema#string

Zaidi M

http://www.w3.org/2001/XMLSchema#string

P2860

Peptides from the calcitonin genes: molecular genetics, structure and function

Evidence that the head of kinesin is sufficient for force generation and motility in vitro

Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo

"Calcium receptors" on eukaryotic cells with special reference to the osteoclast.

EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages.

Regulatory functions of the vascular endothelium.

Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.

The pathobiology of the osteoclast.

Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism.

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

P304

2936-2940

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.88.7.2936

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

1991-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21307265

http://www.w3.org/2001/XMLSchema#string

P698

1849281

http://www.w3.org/2001/XMLSchema#string

P932

51355

http://www.w3.org/2001/XMLSchema#string